$48M sweet spot round size
Most of their 4 investments are in rounds between $18M and $72M
2012
Tvardi Therapeutics raised $72M on June 15, 2021
Investors: Sporos Bioventures and Slate Path Capital LP
Cyclerion raised $18M on June 4, 2021
Investors: Lincoln Park Capital, LLC, The Invus Group, Polaris Partners and Slate Path Capital LP
Undisclosed raised $200M on November 17, 2020
Investors: Omega Advisors and Slate Path Capital LP
Cyclerion raised $24M on July 31, 2020
Investors: Pappas Capital and Slate Path Capital LP